Search IPOs
Subscription Status · Dec 31 – Jan 02, 2026 · ₹85–90
The Modern Diagnostic & Research Centre IPO subscription has recorded exceptional investor demand with an overall subscription of 376.90× as of Jan 02, 2026, indicating that investors applied for 376.90 times the number of shares on offer. All investor categories (institutional, HNI, and retail) have participated actively, making this one of the closely watched IPO openings.
Last updated: Jan 02, 2026, 11:32 PM IST
| Category | Shares Offered | Shares Bid For | Times Subscribed | Applications |
|---|---|---|---|---|
|
QIB
Qualified Institutional Buyers
|
782,400 | 151,400,000 |
193.51×
|
- |
|
NII
Non-Institutional Investors
|
585,600 | 411,139,200 |
702.08×
|
- |
|
bNII
Bids above ₹10L
|
393,600 | 336,852,800 |
855.83×
|
- |
|
sNII
Bids below ₹10L
|
192,000 | 74,286,400 |
386.91×
|
- |
|
Retail
Retail Individual Investors
|
1,363,200 | 466,844,800 |
342.46×
|
- |
|
Total
|
2,731,200 | 1,029,384,000 |
376.90×
|
- |
How subscription built up across investor categories over time
Snapshot of each day's bidding activity
| Category | Offered | Bid For | Times | Applications |
|---|---|---|---|---|
| QIB | 782,400 | 6,998,400 | 8.94× | - |
| bNII | 393,600 | 24,961,600 | 63.42× | - |
| sNII | 192,000 | 6,201,600 | 32.30× | - |
| Individual Investors | 1,363,200 | 46,140,800 | 33.85× | - |
| Anchor | 1,161,600 | 1,161,600 | 1.00× | - |
| Others | 206,400 | 206,400 | 1.00× | - |
| Total | 2,145,600 | 53,139,200 | 24.77× | - |
| Category | Offered | Bid For | Times | Applications |
|---|---|---|---|---|
| QIB | 782,400 | 151,400,000 | 193.51× | - |
| NII | 585,600 | 411,139,200 | 702.08× | - |
| bNII | 393,600 | 336,852,800 | 855.83× | - |
| sNII | 192,000 | 74,286,400 | 386.91× | - |
| Retail | 1,363,200 | 466,844,800 | 342.46× | - |
| Total | 2,731,200 | 1,029,384,000 | 376.90× | - |
As of January 02, 2026, the Modern Diagnostic & Research Centre IPO has been subscribed 376.90 times overall. The IPO is fully subscribed with strong investor demand indicating extremely high interest.
The Modern Diagnostic & Research Centre IPO subscription window was open from December 31, 2025 to January 02, 2026. Investors could apply through their demat account or ASBA facility.
The Modern Diagnostic & Research Centre IPO has a price band of ₹85 to ₹90 per share, with a lot size of 1,600 shares. Minimum retail investment: ₹136,000 (lower band) or ₹144,000 (upper band).
The QIB category has been subscribed 193.51 times. QIBs were offered 782,400 shares. Strong QIB subscription indicates high institutional confidence.
Retail investors subscribed 342.46 times. Retail was offered 1,363,200 shares. High retail subscription reflects strong small-investor interest.
Overall NII: 702.08×. bNII (>₹10L): 855.83×, sNII (<₹10L): 386.91×. NII includes HNIs and corporate entities investing above ₹2 lakh.
Basis of allotment is on January 05, 2026. Check via the registrar's website, MUFG Intime India Pvt.Ltd using your PAN number, application number, or DP/Client ID. You can also check on BSE/NSE websites or through your broker's app.
Modern Diagnostic & Research Centre IPO is expected to list on January 07, 2026. Shares will list on BSE SME platform. Allotted shares are credited to your demat account 1 business day before listing.
A subscription multiple of 376.90× means investors have bid for 376.90 times the total shares available. Since the IPO is oversubscribed, not every applicant will receive shares, allotment happens via lottery (for retail) or proportionately (for other categories). Higher multiples generally reduce allotment probability.
Based on the current retail subscription of 342.46×, the estimated allotment probability for retail investors is Very Low. Only 1 lot likely via lottery if selected. Retail allotment in oversubscribed IPOs is done by computerised lottery, each valid application has an equal probability regardless of the number of lots applied for.
You can apply for Modern Diagnostic & Research Centre IPO through: (1) ASBA (Application Supported by Blocked Amount) via your bank's net banking or mobile app, (2) UPI-based application through your broker's app (Zerodha, Groww, Angel One, etc.), or (3) directly via your demat account. The amount is blocked in your account and deducted only upon allotment. Applications were accepted from Dec 31 to Jan 02, 2026.
The grey market premium (GMP) reflects unofficial pre-listing trading sentiment. For the latest Modern Diagnostic & Research Centre IPO GMP data, check the IPORise GMP page. Note: GMP is unofficial, speculative, and not a guaranteed indicator of listing price. Use it only as a sentiment signal alongside official subscription data.
New to reading subscription numbers? Read our guide on IPO subscription explained.
Subscription Opens Done
Dec 31, 2025Subscription Closes Done
Jan 02, 2026Basis of Allotment Done
Jan 05, 2026Listing on BSE Done
Jan 07, 2026Only 1 lot likely via lottery if selected. Based on retail subscription of 342.46×.
Retail allotment in oversubscribed IPOs is done by computerised lottery, each valid application has equal odds regardless of lot size applied.
Share Subscription Card
Download a branded image to share on WhatsApp, Twitter, or Telegram
Higher subscription = lower allotment probability. Progress bars compare each category relative to the highest-subscribed category.
